9 results on '"cluster-randomised controlled trial"'
Search Results
2. An antibiotic stewardship programme to reduce inappropriate antibiotic prescribing for acute respiratory infections in rural Chinese primary care facilities: study protocol for a clustered randomised controlled trial
- Author
-
Chao Zhuo, Xiaolin Wei, Zhitong Zhang, Joseph Paul Hicks, Jinkun Zheng, Zhixu Chen, Victoria Haldane, John Walley, Yubao Guan, Hongyan Xu, and Nanshan Zhong
- Subjects
Antibiotic ,Stewardship ,Primary care ,Smart phone app ,Cluster-randomised controlled trial ,Acute respiratory infections ,Medicine (General) ,R5-920 - Abstract
Abstract Background Inappropriate prescribing of antibiotics for acute respiratory infections at the primary care level represents the major source of antibiotic misuse in healthcare, and is a major driver for antimicrobial resistance worldwide. In this study we will develop, pilot and evaluate the effectiveness of a comprehensive antibiotic stewardship programme in China’s primary care hospitals to reduce inappropriate prescribing of antibiotics for acute respiratory infections among all ages. Methods We will use a parallel-group, cluster-randomised, controlled, superiority trial with blinded outcome evaluation but unblinded treatment (providers and patients). We will randomise 34 primary care hospitals from two counties within Guangdong province into the intervention and control arm (1:1 overall ratio) stratified by county (8:9 within-county ratio). In the control arm, antibiotic prescribing and management will continue through usual care. In the intervention arm, we will implement an antibiotic stewardship programme targeting family physicians and patients/caregivers. The family physician components include: (1) training using new operational guidelines, (2) improved management and peer-review of antibiotic prescribing, (3) improved electronic medical records and smart phone app facilitation. The patient/caregiver component involves patient education via family physicians, leaflets and videos. The primary outcome is the proportion of prescriptions for acute respiratory infections (excluding pneumonia) that contain any antibiotic(s). Secondary outcomes will address how frequently specific classes of antibiotics are prescribed, how frequently key non-antibiotic alternatives are prescribed and the costs of consultations. We will conduct a qualitative process evaluation to explore operational questions regarding acceptability, cultural appropriateness and burden of technology use, as well as a cost-effectiveness analysis and a long-term benefit evaluation. The duration of the intervention will be 12 months, with another 24 months’ post-trial long-term follow-up. Discussion Our study is one of the first trials to evaluate the effect of an antibiotic stewardship programme in primary care settings in a low- or middle-income country (LMIC). All interventional activities will be designed to be embedded into routine primary care with strong local ownership. Through the trial we intend to impact on clinical practice and national policy in antibiotic prescription for primary care facilities in rural China and other LMICs. Trial registration ISRCTN, ID: ISRCTN96892547 . Registered on 18 August 2019.
- Published
- 2020
- Full Text
- View/download PDF
3. Effectiveness of the nurse-led Activate intervention in patients at risk of cardiovascular disease in primary care: a cluster-randomised controlled trial.
- Author
-
Westland, Heleen, Schuurmans, Marieke J, Bos-Touwen, Irene D, de Bruin-van Leersum, Marjolein A, Monninkhof, Evelyn M, Schröder, Carin D, de Vette, Daphne A, and Trappenburg, Jaap CA
- Subjects
- *
AGE distribution , *ANALYSIS of covariance , *BEHAVIOR modification , *CARDIOVASCULAR diseases risk factors , *COMPARATIVE studies , *CONFIDENCE intervals , *MENTAL depression , *HEALTH behavior , *HEALTH promotion , *HEALTH status indicators , *LONGITUDINAL method , *MEDICAL referrals , *NURSE-patient relationships , *PRIMARY health care , *RESEARCH funding , *SELF-efficacy , *SELF-management (Psychology) , *WEARABLE technology , *MULTIPLE regression analysis , *SOCIAL support , *EFFECT sizes (Statistics) , *EDUCATIONAL attainment , *BODY mass index , *RANDOMIZED controlled trials , *SEDENTARY lifestyles , *PHYSICAL activity , *EVALUATION of human services programs , *DATA analysis software , *DESCRIPTIVE statistics , *NURSING interventions - Abstract
Background: To understand better the success of self-management interventions and to enable tailoring of such interventions at specific subgroups of patients, the nurse-led Activate intervention is developed targeting one component of self-management (physical activity) in a heterogeneous subgroup (patients at risk of cardiovascular disease) in Dutch primary care. Aim: The aim of this study was to evaluate the effectiveness of the Activate intervention and identifying which patient-related characteristics modify the effect. Methods: A two-armed cluster-randomised controlled trial was conducted comparing the intervention with care as usual. The intervention consisted of four nurse-led behaviour change consultations within a 3-month period. Data were collected at baseline, 3 months and 6 months. Primary outcome was the daily amount of moderate to vigorous physical activity at 6 months. Secondary outcomes included sedentary behaviour, self-efficacy for physical activity, patient activation for self-management and health status. Prespecified effect modifiers were age, body mass index, level of education, social support, depression, patient provider relationship and baseline physical activity. Results: Thirty-one general practices (n = 195 patients) were included (intervention group n = 93; control group n = 102). No significant between-group difference was found for physical activity (mean difference 2.49 minutes; 95% confidence interval -2.1; 7.1; P = 0.28) and secondary outcomes. Patients with low perceived social support (P = 0.01) and patients with a low baseline activity level (P = 0.02) benefitted more from the intervention. Conclusion: The Activate intervention did not improve patients' physical activity and secondary outcomes in primary care patients at risk of cardiovascular disease. To understand the results, the intervention fidelity and active components for effective self-management require further investigation. Trial registration: ClinicalTrials.gov NCT02725203. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
4. An antibiotic stewardship programme to reduce inappropriate antibiotic prescribing for acute respiratory infections in rural Chinese primary care facilities: study protocol for a clustered randomised controlled trial.
- Author
-
Zhuo, Chao, Wei, Xiaolin, Zhang, Zhitong, Hicks, Joseph Paul, Zheng, Jinkun, Chen, Zhixu, Haldane, Victoria, Walley, John, Guan, Yubao, Xu, Hongyan, and Zhong, Nanshan
- Subjects
PRIMARY care ,GOVERNMENT policy ,RESPIRATORY infections ,DRUG resistance in microorganisms ,MOBILE apps ,ELECTRONIC health records - Abstract
Background: Inappropriate prescribing of antibiotics for acute respiratory infections at the primary care level represents the major source of antibiotic misuse in healthcare, and is a major driver for antimicrobial resistance worldwide. In this study we will develop, pilot and evaluate the effectiveness of a comprehensive antibiotic stewardship programme in China's primary care hospitals to reduce inappropriate prescribing of antibiotics for acute respiratory infections among all ages.Methods: We will use a parallel-group, cluster-randomised, controlled, superiority trial with blinded outcome evaluation but unblinded treatment (providers and patients). We will randomise 34 primary care hospitals from two counties within Guangdong province into the intervention and control arm (1:1 overall ratio) stratified by county (8:9 within-county ratio). In the control arm, antibiotic prescribing and management will continue through usual care. In the intervention arm, we will implement an antibiotic stewardship programme targeting family physicians and patients/caregivers. The family physician components include: (1) training using new operational guidelines, (2) improved management and peer-review of antibiotic prescribing, (3) improved electronic medical records and smart phone app facilitation. The patient/caregiver component involves patient education via family physicians, leaflets and videos. The primary outcome is the proportion of prescriptions for acute respiratory infections (excluding pneumonia) that contain any antibiotic(s). Secondary outcomes will address how frequently specific classes of antibiotics are prescribed, how frequently key non-antibiotic alternatives are prescribed and the costs of consultations. We will conduct a qualitative process evaluation to explore operational questions regarding acceptability, cultural appropriateness and burden of technology use, as well as a cost-effectiveness analysis and a long-term benefit evaluation. The duration of the intervention will be 12 months, with another 24 months' post-trial long-term follow-up.Discussion: Our study is one of the first trials to evaluate the effect of an antibiotic stewardship programme in primary care settings in a low- or middle-income country (LMIC). All interventional activities will be designed to be embedded into routine primary care with strong local ownership. Through the trial we intend to impact on clinical practice and national policy in antibiotic prescription for primary care facilities in rural China and other LMICs.Trial Registration: ISRCTN, ID: ISRCTN96892547. Registered on 18 August 2019. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
5. Community-based intervention for depression management at the primary care level in Ha Nam Province, Vietnam: a cluster-randomised controlled trial.
- Author
-
Niemi, Maria, Kiel, Simone, Allebeck, Peter, and Hoan, Le Thi
- Subjects
- *
MENTAL depression , *PRIMARY care , *PSYCHOEDUCATION , *YOGA , *RANDOMIZED controlled trials , *DIAGNOSIS of mental depression , *THERAPEUTICS , *MEDICAL education , *COMMUNITY health services , *COMMUNITY health services administration , *COMPARATIVE studies , *RESEARCH methodology , *MEDICAL cooperation , *MEDICAL screening , *MENTAL status examination , *PATIENT education , *PRIMARY health care , *PSYCHOTHERAPY , *QUESTIONNAIRES , *REGRESSION analysis , *RESEARCH , *EVALUATION research , *SEVERITY of illness index , *PATIENT selection - Abstract
Objective: To evaluate the effectiveness of an intervention including psychoeducation and yoga for depression management at the primary healthcare level in one district in the Hà Nam province, Vietnam.Method: The Patient Health Questionnaire-9 (PHQ-9) was used for depression screening and follow-up. Screened patients were further diagnosed with the Mini-International Neuropsychiatric Diagnostic Interview, by a trained general doctor. A linear regression model, adjusted for age, gender and baseline PHQ-9 score was used to assess whether the intervention leads to decreased depression severity compared to standard care in the control communes.Results: Both groups had similar PHQ-9 scores at baseline. The intervention group had on average significantly lower PHQ-9 scores after the intervention than the control group. Almost half of the patients in the intervention group recovered from depression, whereas nobody did in the control group.Conclusion: The results indicate that the intervention can be more effective than standard care in treating depression. The mean change of the PHQ-9 score after the intervention is deemed to be of clinical relevance. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
6. Patient education in chronic heart failure in primary care (ETIC) and its impact on patient quality of life: design of a cluster randomised trial.
- Author
-
Vaillant-Roussel, Hélène, Laporte, Catherine, Pereira, Bruno, Cassagnes, Jean, Ruivard, Marc, Clément, Gilles, Reste, Jean-Yves, Lebeau, Jean-Pierre, Chenot, Jean-François, Pouchain, Denis, Dubray, Claude, and Vorilhon, Philippe
- Subjects
- *
CHI-squared test , *CHRONIC diseases , *STATISTICAL correlation , *FISHER exact test , *HEALTH surveys , *HEART failure , *PATIENT education , *PRIMARY health care , *QUALITY of life , *QUESTIONNAIRES , *RESEARCH funding , *STATISTICS , *STATISTICAL power analysis , *RANDOMIZED controlled trials , *INTER-observer reliability , *DATA analysis software , *DESCRIPTIVE statistics , *KAPLAN-Meier estimator - Abstract
Background Chronic heart failure, a common pathology, is increasing due to the aging population and improvements in heart disease detection and management. The prevalence is estimated at ~10% of the French general practice patient population over 59 years old. The primary objective of this study is to improve the quality of life for heart failure patients though a complex intervention involving patient and general practitioner (GP) education in primary care. Methods A randomised, cluster controlled trial, stratified over 4 areas of the Auvergne region in France comparing intervention and control groups. The inclusion criteria are: patients older than 50 years with New York Heart Association stage I, II, or III heart failure, with reduced ejection fraction or with preserved ejection fraction. Heart failure should be confirmed by the patient?s cardiologist according to the European Society of Cardiology guidelines criteria. The exclusion criteria include: severe cognitive disorders, living in an institution, participating in another clinical trial, having New York Heart Association stage IV heart failure, or a lack of French language skills. The complex intervention consists of training at the GP practice with an interactive 2-day workshop to provide a patient?s education programme. GPs are trained to perform case management, lifestyle counselling and motivational interviewing, to educate patients on the main topics including clinical alarm signs, physical activity, diet and cardiovascular risk factors. The patients? education sessions are scheduled at 1, 4, 7, 10, 13 and 19 months following the start of the trial. The primary outcome to be assessed is the impact on the quality of life as determined using two questionnaires: the Minnesota Living with Heart Failure Questionnaire and SF-36. To detect a difference in the mean quality of life at 19 months, we anticipate studying a minimum of 400 patients from 80 GPs. Discussion This trial will provide insight into the effectiveness of a complex intervention to educate patients with heart failure including a 2-day GP workshop and patients? education programme in the setting of a GP consultation to improve the quality of life in patients with chronic heart failure. This complex intervention tool could be used during initial and further medical training. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
7. Reduction of potentially inappropriate medication in the elderly: design of a cluster-randomised controlled trial in German primary care practices (RIME)
- Author
-
Ulrich Thiem, Stefan Wilm, Petra A. Thürmann, Christiane A Müller, Wolfgang Greiner, Hans J. Trampisch, Henrik Rudolf, and Gudrun Theile
- Subjects
medicine.medical_specialty ,Drug-drug interaction ,cluster-randomised controlled trial ,Primary care ,030204 cardiovascular system & hematology ,elderly ,medication therapy management ,German ,03 medical and health sciences ,Study Protocol ,primary care ,0302 clinical medicine ,hemic and lymphatic diseases ,Medication therapy management ,medicine ,Pharmacology (medical) ,030212 general & internal medicine ,Cluster randomised controlled trial ,drug–drug interaction ,Intensive care medicine ,business.industry ,lcsh:RM1-950 ,language.human_language ,3. Good health ,lcsh:Therapeutics. Pharmacology ,potentially inappropriate medication ,language ,business - Abstract
Background: Potentially inappropriate medication (PIM) is considered to have potentially more harmful than beneficial health effects in elderly patients. A German example for a PIM list is the PRISCUS list that has been available since 2010. PIMs are associated with an increased risk of hospitalisation and adverse health outcomes. Furthermore, drug–drug interactions (DDI) may pose additional risks to patients. It is not yet clear how numbers of PIM and DDI can be reduced in community-dwelling seniors in primary care; nor is it clear whether patients would benefit from such deprescribing. Methods: The cluster-randomised controlled study on the “Reduction of potentially Inappropriate Medication in the Elderly” (RIME study) is designed to examine whether an intervention based on the PRISCUS list can lower the proportion of community-dwelling people of ⩾70 years taking at least one PIM and/or medication inducing at least one dangerous DDI. The intervention consists of professional education and training on the reduction of PIM and DDI, and will be offered to either general practitioners (GPs) alone or GPs and their office staff in the experimental study arm. The control group will be offered professional education and training on more general issues of prescribing in the elderly, not specifically addressing PIM or DDI. The primary endpoint is the difference in the proportion of patients with at least one PIM or DDI between the start of the study and study closure after 12 months as compared between intervention and control group. Secondary endpoints include overall mortality, number of hospitalisations during the course of the study, quality of life and costs. Secondary analyses will be explorative, with the cluster randomisation being factored in. Discussion: The RIME study will contribute to answering the question of whether an intervention based on the PRISCUS list can reduce the proportion of community-dwelling seniors aged ⩾70 years with at least one PIM and/or DDI, and whether this will result in positive health effects, for example, as regards hospitalisations. Trial registration The Study has been registered in the German Clinical Trials Register (DRKS) under the number DRKS00003610. Lay summary Reduction of potentially inappropriate medication in the elderly Improper medication is a common problem in elderly with chronic diseases, and especially those with multiple diseases. Improper medication is assumed to cause side effects, reduced quality of life, more hospital admissions and other negative consequences. Improper medication may by avoided by lists like the German PRISCUS list published in 2010. The list contains drugs that are assumed to be improper in the opinion of experts. The list also gives hints how drugs may interact, and how drugs should be dosed appropriately. A training of general practitioners based on such a list may reduce improper medication. To evaluate this, a scientific project is planned and conducted. In a total of 140 general practitioner offices in the cities of Witten and Hannover, 12 patients in each office aged ⩾70 years and taking at least 6 drugs on a regular basis will be examined. The treating physicians will either get usual recommendations towards pharmacotherapy in the elderly, or they will be advised and trained in new developed recommendations based on the PRISCUS list. After 12 months, the proportion of patients receiving at least one improper medication will be assessed, and the proportions will be compared between the differently trained physician groups. It is assumed that one in four patients will get at least one improper medication, and that the new developed recommendations will reduce the proportion of patients with improper medication by a third.
- Published
- 2020
8. An antibiotic stewardship programme to reduce inappropriate antibiotic prescribing for acute respiratory infections in rural Chinese primary care facilities: study protocol for a clustered randomised controlled trial
- Author
-
Yubao Guan, Chao Zhuo, Victoria Haldane, Zhixu Chen, Jinkun Zheng, Xiaolin Wei, Nanshan Zhong, John Walley, Zhitong Zhang, Hongyan Xu, and Joseph P. Hicks
- Subjects
Rural Population ,Cluster-randomised controlled trial ,medicine.medical_specialty ,China ,Acute respiratory infections ,Cost-Benefit Analysis ,030231 tropical medicine ,Medicine (miscellaneous) ,Inappropriate Prescribing ,Ambulatory Care Facilities ,law.invention ,03 medical and health sciences ,Antimicrobial Stewardship ,Study Protocol ,0302 clinical medicine ,Randomized controlled trial ,Patient Education as Topic ,law ,Health care ,medicine ,Antimicrobial stewardship ,Humans ,Stewardship ,Pharmacology (medical) ,030212 general & internal medicine ,Cluster randomised controlled trial ,Medical prescription ,Respiratory Tract Infections ,Qualitative Research ,lcsh:R5-920 ,Primary Health Care ,business.industry ,Medical record ,Antibiotic ,Physicians, Family ,Drug Resistance, Microbial ,Smart phone app ,Antibiotic misuse ,Primary care ,Mobile Applications ,Caregivers ,Family medicine ,Acute Disease ,Smartphone ,business ,lcsh:Medicine (General) ,Patient education ,Follow-Up Studies - Abstract
Background Inappropriate prescribing of antibiotics for acute respiratory infections at the primary care level represents the major source of antibiotic misuse in healthcare, and is a major driver for antimicrobial resistance worldwide. In this study we will develop, pilot and evaluate the effectiveness of a comprehensive antibiotic stewardship programme in China’s primary care hospitals to reduce inappropriate prescribing of antibiotics for acute respiratory infections among all ages. Methods We will use a parallel-group, cluster-randomised, controlled, superiority trial with blinded outcome evaluation but unblinded treatment (providers and patients). We will randomise 34 primary care hospitals from two counties within Guangdong province into the intervention and control arm (1:1 overall ratio) stratified by county (8:9 within-county ratio). In the control arm, antibiotic prescribing and management will continue through usual care. In the intervention arm, we will implement an antibiotic stewardship programme targeting family physicians and patients/caregivers. The family physician components include: (1) training using new operational guidelines, (2) improved management and peer-review of antibiotic prescribing, (3) improved electronic medical records and smart phone app facilitation. The patient/caregiver component involves patient education via family physicians, leaflets and videos. The primary outcome is the proportion of prescriptions for acute respiratory infections (excluding pneumonia) that contain any antibiotic(s). Secondary outcomes will address how frequently specific classes of antibiotics are prescribed, how frequently key non-antibiotic alternatives are prescribed and the costs of consultations. We will conduct a qualitative process evaluation to explore operational questions regarding acceptability, cultural appropriateness and burden of technology use, as well as a cost-effectiveness analysis and a long-term benefit evaluation. The duration of the intervention will be 12 months, with another 24 months’ post-trial long-term follow-up. Discussion Our study is one of the first trials to evaluate the effect of an antibiotic stewardship programme in primary care settings in a low- or middle-income country (LMIC). All interventional activities will be designed to be embedded into routine primary care with strong local ownership. Through the trial we intend to impact on clinical practice and national policy in antibiotic prescription for primary care facilities in rural China and other LMICs. Trial registration ISRCTN, ID: ISRCTN96892547. Registered on 18 August 2019.
- Published
- 2020
9. Patient education in chronic heart failure in primary care (ETIC) and its impact on patient quality of life: design of a cluster randomised trial
- Author
-
Bruno Pereira, Catherine Laporte, Denis Pouchain, Jean-Yves Le Reste, Claude Dubray, Gilles Clément, Jean-Pierre Lebeau, Philippe Vorilhon, Jean-François Chenot, Gilles Tanguy, Marc Ruivard, Jean Cassagnes, Hélène Vaillant-Roussel, Departement Médecine Générale [Clermont-Ferrand], Université d'Auvergne - Clermont-Ferrand I (UdA), Centre d'Investigation Clinique [CHU Clermont-Ferrand] (CIC 1405), Institut National de la Santé et de la Recherche Médicale (INSERM)-Direction de la recherche clinique et de l’innovation [CHU Clermont-Ferrand] (DRCI), CHU Clermont-Ferrand-CHU Clermont-Ferrand, Neuro-Psycho Pharmacologie des Systèmes Dopimanégiques sous-corticaux (NPsy-Sydo), CHU Clermont-Ferrand-Université Clermont Auvergne [2017-2020] (UCA [2017-2020]), Unité de Biostatistiques [CHU Clermont-Ferrand], Direction de la recherche clinique et de l’innovation [CHU Clermont-Ferrand] (DRCI), Service de Cardiologie Maladies Vasculaires [CHU Clermont-Ferrand], CHU Gabriel Montpied [Clermont-Ferrand], Service de Médecine Interne [CHU Clermont-Ferrand], Departement Médecine Générale [Brest] (Faculté de Médecine), Université de Brest (UBO), Departement Médecine Générale [Tours] (Faculté de Médecine), Université de Tours (UT), Department of General Practice [Greifswald, Germany] (Institute of Community Medicine), Universität Greifswald - University of Greifswald, Périnatalité, grossesse, Environnement, PRAtiques médicales et DEveloppement (PEPRADE), CHU Clermont-Ferrand-Université d'Auvergne - Clermont-Ferrand I (UdA), This trial received public funding (105 750 euros, 52%) from the French hospital research fund, a grant from the French Ministry of Health (PHRC-Hospital Program of Clinical Research) and regional health agencies (URCAM and GRSP), and private funding (97 500 euros, 48%) from Sanofi-Aventis, ‘le Groupe Pasteur mutualité’ (private medical insurance), and ‘Union régionale des médecins libéraux de la région Auvergne’ (regional primary care physician association)., Université de Tours, and VIGNAL, Alexine
- Subjects
Male ,Quality of life ,Cluster-randomised controlled trial ,medicine.medical_specialty ,[SDV.SP.MED] Life Sciences [q-bio]/Pharmaceutical sciences/Medication ,Heart disease ,law.invention ,Study Protocol ,Randomized controlled trial ,Patient Education as Topic ,[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system ,[SDV.SP.MED]Life Sciences [q-bio]/Pharmaceutical sciences/Medication ,law ,Medicine ,Humans ,Cluster randomised controlled trial ,Disease management (health) ,10. No inequality ,Aged ,Heart Failure ,Primary Health Care ,business.industry ,Disease Management ,Patient education ,Middle Aged ,medicine.disease ,Primary care ,[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system ,3. Good health ,Clinical trial ,Treatment Outcome ,Heart failure ,Chronic Disease ,Physical therapy ,Female ,France ,business ,Family Practice - Abstract
Background Chronic heart failure, is increasing due to the aging population and improvements in heart disease detection and management. The prevalence is estimated at ~10% of the French general practice patient population over 59 years old. The primary objective of this study is to improve the quality of life for heart failure patients though a complex intervention involving patient and general practitioner (GP) education in primary care. Methods A randomised, cluster controlled trial, stratified over 4 areas of the Auvergne region in France comparing intervention and control groups. The inclusion criteria are: patients older than 50 years with New York Heart Association (NYHA) stage I, II, or III heart failure, with reduced ejection fraction or with preserved ejection fraction. Heart failure should be confirmed by the patient’s cardiologist according to the European Society of Cardiology guidelines criteria. The exclusion criteria include: severe cognitive disorders, living in an institution, participating in another clinical trial, having NYHA stage IV heart failure, or a lack of French language skills. The complex intervention consists of training at the GP practice with an interactive 2-day workshop to provide a patient’s education programme. GPs are trained to perform case management, lifestyle counselling and motivational interviewing, to educate patients on the main topics including clinical alarm signs, physical activity, diet and cardiovascular risk factors. The patients’ education sessions are scheduled at 1, 4, 7, 10, 13 and 19 months following the start of the trial. The primary outcome to be assessed is the impact on the quality of life as determined using two questionnaires: the Minnesota Living with Heart Failure Questionnaire and SF-36. To detect a difference in the mean quality of life at 19 months, we anticipate studying a minimum of 400 patients from 80 GPs. Discussion This trial will provide insight into the effectiveness of a complex intervention to educate patients with heart failure including a 2-day GP workshop and patients’ education programme in the setting of a GP consultation to improve the quality of life in patients with chronic heart failure. This complex intervention tool could be used during initial and further medical training. Trial registration ETIC is a cluster-randomised, controlled trial registered on ClinicalTrials.gov [NCT01065142, 2010, Feb 8] and the French drug agency [Agence Nationale de Sécurité du Médicament et des produits de santé; registration number: 2009-A01142-55, on March 5th, 2010]. Electronic supplementary material The online version of this article (doi:10.1186/s12875-014-0208-3) contains supplementary material, which is available to authorized users.
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.